Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112724003B reveals a safer, high-yield route for 9-fluorenylformaldehyde using mixed alkoxides, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101429192A details a novel chiral titanium catalysis method for high-purity proton pump inhibitor intermediates, offering significant supply chain and cost advantages.
Novel fragment condensation method for Liraglutide improves purity and yield while reducing resin consumption for scalable manufacturing processes.
Patent CN111235123A reveals a novel carbonyl reductase enabling high-substrate loading biocatalysis, offering significant cost reduction and purity advantages for pharmaceutical manufacturing.
Patent CN110577941A reveals mutated amine dehydrogenase for asymmetric reductive amination. Enables cost reduction in pharmaceutical intermediates manufacturing with high optical purity.
Patent CN111100851B discloses high-efficiency TbSADH mutants for synthesizing chiral biaryl alcohols with >99% ee, offering a green alternative to metal catalysis.
Novel TbSADH mutants enable high-yield synthesis of chiral biaryl alcohols. Efficient biocatalysis for pharmaceutical intermediates with superior stereoselectivity.
Patent CN114736882B reveals high-efficiency biocatalysis for antiviral intermediates. Offers supply chain stability and cost reduction in API manufacturing without heavy metals.
Patent CN102993256B reveals mild ammonium salt method for selective sugar deprotection. Enhances supply chain reliability and reduces manufacturing complexity significantly.
Patent CN106496193A enables high-purity nilotinib synthesis with superior yield and scalable production for global pharmaceutical supply chains and cost efficiency.
Novel aminotransferase mutants enable high-yield sitagliptin synthesis. Cost-effective, scalable pharma intermediate solution with >99% ee.
Novel Ti-catalyzed method offers mild conditions and high yields for beta-aminocarboxylate production, ensuring cost-effective supply chain solutions.
Patent CN115611961A reveals a mild elimination route for Cholic Acid Intermediate A2, enabling virus-free API production with scalable supply chain advantages.
Novel transaminase mutant enables high-yield sitagliptin intermediate synthesis with superior stereoselectivity and scalable biocatalytic process efficiency for global supply.
Discover a novel bromfenac sodium synthesis method avoiding indole impurities. Enhanced purity, stable pH, and scalable production for pharmaceutical supply chains.
Patent CN115611961A details a novel chemical synthesis for Cholic Acid Intermediate A2, offering a virus-free alternative to animal extraction with scalable manufacturing capabilities.
Novel cobalt-catalyzed synthesis of indole alkaloids offering high yield and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN109825849A reveals a metal-free electrochemical route for trifluoromethyl vinylic compounds, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel LiOH and DMSO hydrolysis method ensures high purity Bempedoic acid intermediate with reduced safety risks and scalable production capabilities for global supply chains.
Patent CN116396950B reveals novel carboxylesterase mutants for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.